AAAAAA

   
Results: 1-14 |
Results: 14
STRUCTURE-ACTIVITY-RELATIONSHIPS OF A SERIES OF 1-SUBSTITUTED-4-METHYLBENZIMIDAZOLE NEUROPEPTIDE Y-1 RECEPTOR ANTAGONISTS
Authors: ZIMMERMAN DM CANTRELL BE SMITH ECR NIXON JA BRUNS RF GITTER B HIPSKIND PA ORNSTEIN PL ZARRINMAYEH H BRITTON TC SCHOBER DA GEHLERT DR
Citation: Dm. Zimmerman et al., STRUCTURE-ACTIVITY-RELATIONSHIPS OF A SERIES OF 1-SUBSTITUTED-4-METHYLBENZIMIDAZOLE NEUROPEPTIDE Y-1 RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 8(5), 1998, pp. 473-476
THE NEUROPEPTIDE-Y Y-1 ANTAGONIST, 1229U91, A POTENT AGONIST FOR THE HUMAN PANCREATIC POLYPEPTIDE-PREFERRING (NPY Y-4) RECEPTOR
Authors: SCHOBER DA VANABBEMA AM SMILEY DL BRUNS RF GEHLERT DR
Citation: Da. Schober et al., THE NEUROPEPTIDE-Y Y-1 ANTAGONIST, 1229U91, A POTENT AGONIST FOR THE HUMAN PANCREATIC POLYPEPTIDE-PREFERRING (NPY Y-4) RECEPTOR, Peptides, 19(3), 1998, pp. 537-542
SYNTHESIS AND EVALUATION OF A SERIES OF NOVEL 2-[(4-CHLOROPHENOXY)METHYL]BENZIMIDAZOLES AS SELECTIVE NEUROPEPTIDE-Y Y1 RECEPTOR ANTAGONISTS
Authors: ZARRINMAYEH H NUNES AM ORNSTEIN PL ZIMMERMAN DM ARNOLD MB SCHOBER DA GACKENHEIMER SL BRUNS RF HIPSKIND PA BRITTON TC CANTRELL BE GEHLERT DR
Citation: H. Zarrinmayeh et al., SYNTHESIS AND EVALUATION OF A SERIES OF NOVEL 2-[(4-CHLOROPHENOXY)METHYL]BENZIMIDAZOLES AS SELECTIVE NEUROPEPTIDE-Y Y1 RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 41(15), 1998, pp. 2709-2719
POTENT AND SELECTIVE 1,2,3-TRISUBSTITUTED INDOLE NPY Y-1 ANTAGONISTS
Authors: HIPSKIND PA LOBB KL NIXON JA BRITTON TC BRUNS RF CATLOW J DIECKMANMCGINTY DK GACKENHEIMER SL GITTER BD IYENGAR S SCHOBER DA SIMMONS RMA SWANSON S ZARRINMAYEH H ZIMMERMAN DM GEHLERT DR
Citation: Pa. Hipskind et al., POTENT AND SELECTIVE 1,2,3-TRISUBSTITUTED INDOLE NPY Y-1 ANTAGONISTS, Journal of medicinal chemistry, 40(23), 1997, pp. 3712-3714
CONFORMATIONAL INDUCTION VERSUS CONFORMATIONAL SELECTION - EVIDENCE FROM ALLOSTERIC ENHANCERS
Authors: BRUNS RF
Citation: Rf. Bruns, CONFORMATIONAL INDUCTION VERSUS CONFORMATIONAL SELECTION - EVIDENCE FROM ALLOSTERIC ENHANCERS, Trends in pharmacological sciences, 17(5), 1996, pp. 189-189
3-ARYL-1,2-DIACETAMIDOPROPANE DERIVATIVES AS NOVEL AND POTENT NK-1 RECEPTOR ANTAGONISTS
Authors: HIPSKIND PA HOWBERT JJ BRUNS RF CHO SSY CROWELL TA FOREMAN MM GEHLERT DR IYENGAR S JOHNSON KW KRUSHINSKI JH LI DL LOBB KL MASON NR MUEHL BS NIXON JA PHEBUS LA REGOLI D SIMMONS RM THRELKELD PG WATERS DC GITTER BD
Citation: Pa. Hipskind et al., 3-ARYL-1,2-DIACETAMIDOPROPANE DERIVATIVES AS NOVEL AND POTENT NK-1 RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 39(3), 1996, pp. 736-748
PD-81,723, AN ALLOSTERIC ENHANCER OF THE A(1) ADENOSINE RECEPTOR, LOWERS THE THRESHOLD FOR ISCHEMIC PRECONDITIONING IN DOGS
Authors: MIZUMURA T AUCHAMPACH JA LINDEN J BRUNS RF GROSS GJ
Citation: T. Mizumura et al., PD-81,723, AN ALLOSTERIC ENHANCER OF THE A(1) ADENOSINE RECEPTOR, LOWERS THE THRESHOLD FOR ISCHEMIC PRECONDITIONING IN DOGS, Circulation research, 79(3), 1996, pp. 415-423
CYCLOSPORINE-A IS A SUBSTANCE-P (TACHYKININ NK1) RECEPTOR ANTAGONIST
Authors: GITTER BD WATERS DC THRELKELD PG LOVELACE AM MATSUMOTO K BRUNS RF
Citation: Bd. Gitter et al., CYCLOSPORINE-A IS A SUBSTANCE-P (TACHYKININ NK1) RECEPTOR ANTAGONIST, European journal of pharmacology. Molecular pharmacology section, 289(3), 1995, pp. 439-446
MEDICINAL CHEMISTRY OF DIFLUOROPURINES
Authors: ANDIS SL BEWLEY JR BODER GB BURKE T DUDLEY DE EICHELBERGER LE GROSSMAN CS GRINDEY GB HERTEL LW JORDAN CL KROIN JS MARLOW D PATEL VF RINZEL S RUTHERFORD PG SHELF TD SEYMOUR PD SCHULTZ RM WEIR LC WORZALLA JF EHLHARDT WJ WOODLAND JM BRUNS RF ZIMMERMANN JL TODD G SARAZAN DR
Citation: Sl. Andis et al., MEDICINAL CHEMISTRY OF DIFLUOROPURINES, Seminars in oncology, 22(4), 1995, pp. 54-60
PHARMACOLOGICAL CHARACTERIZATION OF LY303870 - A NOVEL, POTENT AND SELECTIVE NONPEPTIDE SUBSTANCE-P (NEUROKININ-1) RECEPTOR ANTAGONIST
Authors: GITTER BD BRUNS RF HOWBERT JJ WATERS DC THRELKELD PG COX LM NIXON JA LOBB KL MASON NR STENGEL PW COCKERHAM SL SILBAUGH SA GEHLERT DR SCHOBER DA IYENGAR S CALLIGARO DO REGOLI D HIPSKIND PA
Citation: Bd. Gitter et al., PHARMACOLOGICAL CHARACTERIZATION OF LY303870 - A NOVEL, POTENT AND SELECTIVE NONPEPTIDE SUBSTANCE-P (NEUROKININ-1) RECEPTOR ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 275(2), 1995, pp. 737-744
PD81,723, AN ALLOSTERIC ENHANCER OF THE ADENOSINE-A1-RECEPTOR, LOWERSTHE THRESHOLD FOR ISCHEMIC PRECONDITIONING IN DOGS
Authors: MIZUMURA T BRUNS RF GROSS GJ
Citation: T. Mizumura et al., PD81,723, AN ALLOSTERIC ENHANCER OF THE ADENOSINE-A1-RECEPTOR, LOWERSTHE THRESHOLD FOR ISCHEMIC PRECONDITIONING IN DOGS, Circulation, 92(8), 1995, pp. 2505-2505
ALLOSTERIC ENHANCER PD-81,723 ACTS BY NOVEL MECHANISM TO POTENTIATE CARDIAC ACTIONS OF ADENOSINE
Authors: KOLLIASBAKER C RUBLE J DENNIS D BRUNS RF LINDEN J BELARDINELLI L
Citation: C. Kolliasbaker et al., ALLOSTERIC ENHANCER PD-81,723 ACTS BY NOVEL MECHANISM TO POTENTIATE CARDIAC ACTIONS OF ADENOSINE, Circulation research, 75(6), 1994, pp. 961-971
DIPHENYLPYRAZOLIDINONE AND BENZODIAZEPINE CHOLECYSTOKININ ANTAGONISTS- A CASE OF CONVERGENT EVOLUTION IN MEDICINAL CHEMISTRY
Authors: HOWBERT JJ LOBB KL BRITTON TC MASON NR BRUNS RF
Citation: Jj. Howbert et al., DIPHENYLPYRAZOLIDINONE AND BENZODIAZEPINE CHOLECYSTOKININ ANTAGONISTS- A CASE OF CONVERGENT EVOLUTION IN MEDICINAL CHEMISTRY, Bioorganic & medicinal chemistry letters, 3(5), 1993, pp. 875-880
SELECTIVE POTENTIATION BY AN A(1) ADENOSINE RECEPTOR ENHANCER OF THE NEGATIVE DROMOTROPIC ACTION OF ADENOSINE IN THE GUINEA-PIG HEART
Authors: AMOAHAPRAKU B XU J LU JY PELLEG A BRUNS RF BELARDINELLI L
Citation: B. Amoahapraku et al., SELECTIVE POTENTIATION BY AN A(1) ADENOSINE RECEPTOR ENHANCER OF THE NEGATIVE DROMOTROPIC ACTION OF ADENOSINE IN THE GUINEA-PIG HEART, The Journal of pharmacology and experimental therapeutics, 266(2), 1993, pp. 611-617
Risultati: 1-14 |